BETHLEHEM, PA--(Marketwired - Sep 13, 2016) - B. Braun Medical Inc. will exhibit the latest advancements to its vascular access portfolio at this year's 30th Association for Vascular Access (AVA) Annual Scientific Meeting at Disney's Coronado Springs Resort in Orlando, Sept.16-19.
B. Braun will unveil its new STEADYCare™ Extension Set with Wedge™ Catheter Stabilizer - developed to help improve stabilization and reduce catheter-related complications. It was designed to minimize catheter movement in the vessel, maintain the catheter insertion angle, and reduce the patient connector's skin contact. Visitors to booth #309 will be able to see and handle the new STEADYCare at AVA and the product will be available for sale in October.
"B. Braun's goal is to expand the vision of peripheral IV care beyond individual focus areas," said Tom Sutton, Vice President of Vascular Access Systems at B. Braun. "We're committed to collaborating with healthcare providers to improve the quality and efficiency of healthcare delivery and outcomes. STEADYCare represents the latest advancement in IV therapy technology."
The company also will feature its new Ster-ASSIST™ Sterile Peripheral IV Catheter Insertion Kit, one of the first comprehensive sterile IV kits supporting ultrasound-guided PIV insertion. To promote best practices in sterile technique and clinician safety, while still providing convenience, B. Braun has packaged into a single kit all of the components needed to perform ultrasound-guided peripheral IV therapy procedures.
At its booth #309, B. Braun will showcase the following products and have an ultrasound PIVC placement demonstration station where attendees will be able to practice insertion techniques with the use of ultrasound. Attendees also will be able to visit distinct areas within the booth to learn how they can improve peripheral IV access.
- Introcan Safety® IV Catheter - Designed with innovative, fully automatic passive-safety features to help eliminate accidental needlestick injury. From needle removal to disposal, clinicians are protected by a passive-safety device that is activated automatically -- no extra steps required and cannot be bypassed.
- Introcan Safety® 3 Closed IV Catheter - B. Braun's latest advancement, which takes the same preferred passive-safety engineered needlestick protection found in Introcan Safety and adds additional automatic protection from blood exposure. For safety and convenience, Introcan Safety 3's unique multi-access blood control septum is designed to minimize blood exposure during needle removal and each time the catheter hub is accessed.
- InVision-Plus® Neutral IV Connector - The most recent addition to the B. Braun needleless connector portfolio provides a 10-point standard of features and is offered through an exclusive U.S. distribution agreement with RyMed Technologies, LLC. B. Braun's portfolio of needleless connectors, including the CARESITE® Luer Access Device, offers a safe way to access IV lines through innovative features designed to help reduce catheter occlusions while protecting healthcare workers from accidental needlestick injuries.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is part of the B. Braun Group of Companies in the U.S., which is headquartered in Bethlehem, Pa., and includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 56,000 employees in more than 60 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.